Hodgkin Disease

Showing 51 - 75 of 91

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin Disease Trial in United States (Lenalidomide)

Completed
  • Hodgkin Disease
  • Saint Louis, Missouri
  • +4 more
Oct 5, 2017

Factors on Platelet Concentrate Transfusion Response in

Completed
  • Lymphoma
  • +3 more
  • Platelet concentrate transfusion
  • (no location specified)
Sep 29, 2017

Hodgkin Disease, Hodgkin's Lymphoma, Lymphoma Trial in Stanford (Gemcitabine, Vinorelbine, Carmustine)

Completed
  • Hodgkin Disease
  • +2 more
  • Stanford, California
    Stanford University School of Medicine
May 15, 2017

Leukemia, Myeloid, Acute, Leukemia, Myelogenous, Chronic, Leukemia, Lymphoblastic, Acute Trial in Saint Louis (AMD3100, Stem

Completed
  • Leukemia, Myeloid, Acute
  • +7 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 5, 2017

Leukemia, Myeloid, Acute, MDS, Lymphoma, Non-Hodgkin Trial in Saint Louis (Sargramostim, Plerixafor)

Completed
  • Leukemia, Myeloid, Acute
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
May 3, 2017

Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone

Unknown status
  • Chronic Kidney Disease
  • +16 more
  • Haploidentical Bone Marrow/Kidney
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 21, 2017

Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in St. Louis (AMD3100, G-CSF, Apheresis)

Completed
  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • St. Louis, Missouri
    Washington University School of Medicine
Jan 26, 2017

Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in St. Louis (Abraxane)

Terminated
  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • St. Louis, Missouri
  • +1 more
Dec 5, 2016

Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Palo Alto (SD-101, Local Radiation)

Terminated
  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • Palo Alto, California
    Stanford University School of Medicine
Nov 17, 2016

GVHD, MDS, Leukemia Trial run by the NHLBI (RFT5-SMPT-dgA, Isolex system)

Completed
  • Graft vs Host Disease
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 21, 2016

Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in Lexington (Azacitidine with rituximab, vincristine, and

Completed
  • Lymphoma
  • +2 more
  • Azacitidine with rituximab, vincristine, and cyclophosphamide
  • Lexington, Kentucky
    University of Kentucky
Oct 13, 2016

Hodgkin Disease, Breast Cancer Trial in Marseille (intensive screening)

Terminated
  • Hodgkin Disease
  • Breast Cancer
  • intensive screening
  • Marseille, France
    François EISINGER, PhD
Oct 13, 2016

Hodgkin Disease Trial in Spain (Ofatumumab)

Completed
  • Hodgkin Disease
  • Badalona, Barcelona, Spain
  • +13 more
Feb 23, 2016

Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Riyadh (Cytogenetic Analysis of Bone Marrow Specimen)

Completed
  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • Cytogenetic Analysis of Bone Marrow Specimen
  • Riyadh, Saudi Arabia
    KFSH&RC
Dec 16, 2015

Lymphoma, Non-Hodgkin, Hodgkin Disease Trial (FDG PET)

Completed
  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • FDG PET
  • (no location specified)
Dec 16, 2015

B-Receptor Signaling in Cardiomyopathy

Completed
  • Carcinomas
  • +37 more
    • Stanford, California
      Stanford University School of Medicine
    Nov 16, 2015

    Hodgkin Disease, Non-Hodgkin Lymphoma, Multiple Myeloma Trial in Köln (moxifloxacin, )

    Completed
    • Hodgkin Disease
    • +3 more
    • Köln, Germany
      Klinikum der Universität zu Köln
    Jun 1, 2015

    Haploidentical Graft Recipients

    Completed
    • Leukemia
    • +4 more
      • Seattle, Washington
        Fred Hutchinson Cancer Research Center
      Mar 9, 2015

      Leukemia, Myeloid, Acute, MDS, Leukemia, Lymphoblastic, Acute Trial in London (Thiotepa, Fludarabine, Intravenous busulphan)

      Terminated
      • Leukemia, Myeloid, Acute
      • +5 more
      • London, United Kingdom
        King's College Hosptial NHS Foundation Trust
      Feb 10, 2015

      Hodgkin Disease Trial in Stanford (Doxorubicin, Vinblastine, Cyclophosphamide)

      Terminated
      • Hodgkin Disease
      • Stanford, California
        Stanford University Medical Center
      Aug 26, 2014

      Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in United States (PCI-24781)

      Completed
      • Lymphoma
      • +2 more
      • San Francisco, California
      • +7 more
      Feb 27, 2014

      Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Atlanta (G-CSF plus plerixafor, rituximab)

      Completed
      • Non-Hodgkin Lymphoma
      • Hodgkin Disease
      • G-CSF plus plerixafor
      • rituximab
      • Atlanta, Georgia
        Winship Cancer Institute
      Feb 10, 2014

      Acute Myeloid Leukemia, Myelodysplasia, Acute Lymphoblastic Leukemia Trial in San Francisco (umbilical cord stem cells)

      Terminated
      • Acute Myeloid Leukemia
      • +9 more
      • umbilical cord stem cells
      • San Francisco, California
        University of California, San Francisco
      Aug 13, 2013

      Leukemia, Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in St. Louis (CD34-TK75 transduced donor lymphocytes, Sub Study - 18 FHBG

      Completed
      • Leukemia
      • +4 more
      • CD34-TK75 transduced donor lymphocytes
      • Sub Study - 18 FHBG PET/CT Scans
      • St. Louis, Missouri
        Washington University School of Medicine
      Jul 9, 2013

      Lymphoma, Non-Hodgkin's Lymphoma, Hodgkin Disease Trial in United States (PCI-24781)

      Completed
      • Lymphoma
      • +5 more
      • Chicago, Illinois
      • +4 more
      Jun 17, 2013